NCT04608591

Brief Summary

  • This study is aimed at identifying patients at high risk for Venous Thrombo-Embolism (VTE) (clots in the veins of legs or clots in the lungs) who have lower limb injuries treated with immobilisation of the lower limb. The study aims to identify high risk patients, who may benefit from thromboprophylaxis (blood thinning medication) to prevent such clots forming.
  • To do this we will collect data on 3500 patients who present with lower limb injury requiring immobilisation to the Emergency Departments of the six hospitals named.
  • We will assess their risk factors for venous thrombosis at the time of presentation and contact them at twelve weeks to assess if they have had a VTE in order to develop a risk scoring system which can be used to predict the likelihood of VTE development
  • This risk scoring system can then be used to identify high risk patients who may benefit from thromboprophylaxis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2018

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 19, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 29, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

October 29, 2020

Status Verified

October 1, 2020

Enrollment Period

5 years

First QC Date

October 19, 2020

Last Update Submit

October 23, 2020

Conditions

Keywords

Venous thromboembolism prophylaxis

Outcome Measures

Primary Outcomes (2)

  • To measure the number of patients who develop venous thromboembolism within a 12 week period after a lower limb injury requiring immobilisation

    All patients who present to the emergency department with lower limb injury ,require lower limb immobilisation and consent to the study will be enrolled in the study. At 12 weeks we will measure the number of patients who have developed a symptomatic venous thromboembolism confirmed by scanning to measure the rate of VTE in this population group.

    12 weeks post trauma and lower limb immobilisation

  • The identification and measurement of the risk factors that contribute to the development of venous thromboembolism in patients with lower limb injury requiring immobilisation

    To record in each participant individual thrombosis risk factors based on the Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis study ( MEGA study) . To identify which of these factors are significantly associated with the development of venous thromboembolism in this population group.

    12 weeks post trauma and immobilisation

Secondary Outcomes (1)

  • To identify a high risk group that will benefit from chemical prophylaxis

    12 weeks post trauma and immobilisation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients who present to the Emergency Departments of participating centres with lower limb injury over 18 requiring lower limb immobilisation.

You may qualify if:

  • All patients who present to the Emergency Department with lower limb trauma requiring lower limb immobilisation. Aged over 18

You may not qualify if:

  • Patient unable to give consent Previous Venous thromboembolism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Denis OKeeffe

Limerick, V94YVHO, Ireland

RECRUITING

Related Publications (4)

  • van Adrichem RA, Nemeth B, Algra A, le Cessie S, Rosendaal FR, Schipper IB, Nelissen RGHH, Cannegieter SC; POT-KAST and POT-CAST Group. Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting. N Engl J Med. 2017 Feb 9;376(6):515-525. doi: 10.1056/NEJMoa1613303. Epub 2016 Dec 3.

    PMID: 27959702BACKGROUND
  • Guyatt GH, Akl EA, Crowther M, Schunemann HJ, Gutterman DD, Lewis SZ. Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):48S-52S. doi: 10.1378/chest.11-2286.

    PMID: 22315255BACKGROUND
  • Nemeth B, van Adrichem RA, van Hylckama Vlieg A, Bucciarelli P, Martinelli I, Baglin T, Rosendaal FR, le Cessie S, Cannegieter SC. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies. PLoS Med. 2015 Nov 10;12(11):e1001899; discussion e1001899. doi: 10.1371/journal.pmed.1001899. eCollection 2015 Nov.

    PMID: 26554832BACKGROUND
  • Ocak G, Vossen CY, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC, Lijfering WM. Risk of venous thrombosis in patients with major illnesses: results from the MEGA study. J Thromb Haemost. 2013 Jan;11(1):116-23. doi: 10.1111/jth.12043.

    PMID: 23106832BACKGROUND

MeSH Terms

Conditions

Venous ThrombosisLeg Injuries

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesWounds and Injuries

Study Officials

  • denis okeeffe, MBBCH

    University of Limerick

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Denis OKEEFFE, MBBCH

CONTACT

Michael Watts, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Haematologist

Study Record Dates

First Submitted

October 19, 2020

First Posted

October 29, 2020

Study Start

December 1, 2018

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

October 29, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

All researchers will input their centre patient data. The overall committee will review all patient data for review purposes . Individual centres will not be able to access other centres data.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
At the end of trial for a limited time.
Access Criteria
Only the reviewing committee will have access to all data. Individual centres will have access to their centres data.

Locations